These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11021957)

  • 21. Inflammation in hypertension.
    Savoia C; Schiffrin EL
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):152-8. PubMed ID: 16481882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease.
    Szasz T; Thakali K; Fink GD; Watts SW
    Exp Biol Med (Maywood); 2007 Jan; 232(1):27-37. PubMed ID: 17202583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms underlying the vascular actions of endothelin 1, angiotensin II and bradykinin in the rat carotid.
    Tirapelli CR; Bonaventura D; Tirapelli LF; de Oliveira AM
    Pharmacology; 2009; 84(2):111-26. PubMed ID: 19657221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antihypertensive treatment on small artery remodeling in hypertension.
    Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):168-76. PubMed ID: 12710531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
    Neutel JM
    J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cellular signalling pathways and pathophysiology of pulmonary arterial hypertension].
    Dao P; Montani D; Duong-Quy S; Dinh-Xuan AT
    Rev Mal Respir; 2006 Feb; 23(1 Suppl):3S75-83. PubMed ID: 16604016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL
    Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox signalling in vascular responses to shear and stretch.
    Lehoux S
    Cardiovasc Res; 2006 Jul; 71(2):269-79. PubMed ID: 16780820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular gap junctions and implications for hypertension.
    Rummery NM; Hill CE
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):659-67. PubMed ID: 15554905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in intracellular signalling in hypertension.
    Touyz RM
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):165-74. PubMed ID: 12589177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of magnesium in the pathogenesis of hypertension.
    Touyz RM
    Mol Aspects Med; 2003; 24(1-3):107-36. PubMed ID: 12537992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme and vascular remodeling.
    Heeneman S; Sluimer JC; Daemen MJ
    Circ Res; 2007 Aug; 101(5):441-54. PubMed ID: 17761934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of vascular smooth muscle cells and mesenchymal stem cells by mechanical strain.
    Kurpinski K; Park J; Thakar RG; Li S
    Mol Cell Biomech; 2006 Mar; 3(1):21-34. PubMed ID: 16711069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of vascular smooth muscle cell migration.
    Gerthoffer WT
    Circ Res; 2007 Mar; 100(5):607-21. PubMed ID: 17363707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
    Shah V
    J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.
    Higuchi S; Ohtsu H; Suzuki H; Shirai H; Frank GD; Eguchi S
    Clin Sci (Lond); 2007 Apr; 112(8):417-28. PubMed ID: 17346243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
    Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
    Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paracrine control of vascular innervation in health and disease.
    Storkebaum E; Carmeliet P
    Acta Physiol (Oxf); 2011 Sep; 203(1):61-86. PubMed ID: 21689379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Importance of extrarenal renin systems in the pathogenesis of arterial hypertension].
    Paul M; Ganten D
    Verh Dtsch Ges Inn Med; 1991; 97():539-44. PubMed ID: 1808942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.